This transcript details the pathological analysis of a subcutaneous tumor, likely on the face, characterized by an unusual appearance including cystic spaces, epithelial nests, and a bluish, purple hue. The speaker, a dermatopathologist, explains the diagnostic approach, emphasizing the importance of distinguishing primary sweat gland tumors from metastatic adenocarcinoma. A key diagnostic tool highlighted is the immunostain P63 or P40, which strongly stains primary cutaneous adnexal tumors while being largely negative in metastatic visceral adenocarcinomas, a distinction critical for patient prognosis. The tumor is ultimately identified as a "mixed tumor" (also known as chondroid syringoma or pleomorphic adenoma), which is an epithelial-myoepithelial tumor. The myoepithelial component is noted for its differentiation into soft tissue elements such as bone, cartilage, and myxoid stroma. The speaker also discusses the potential for malignant transformation (malignant myoepithelioma/carcinoma) when significant atypia is present and reviews the immunohistochemical profile of myoepithelial cells, including strong S100, Sox10, and keratin staining, which helps differentiate them from melanoma.
Summary of the Transcript: Subcutaneous Mixed Tumor Pathology
0:00:01 - Initial Presentation: A subcutaneous tumor, likely on the face, characterized by large sweat and sebaceous glands, cystic spaces, epithelial nests or islands, and a distinctive bluish/purple appearance.
0:00:22 - Nature of Cystic Spaces: The cystic spaces are identified as true cysts lined by epithelial cells, indicating glandular or cystic differentiation within the tissue.
0:00:27 - Dr. Weed's Rule for White Spaces: A fundamental rule states that any clear white space in tissue is either an epithelial-lined space (gland/cyst), a lymphovascular space (lined by endothelium), or an artifact (due to lipid washout, tissue damage, or foreign body).
0:01:06 - Differential Diagnosis - Sweat Gland Tumor vs. Metastasis: The presence of epithelial-lined spaces suggests a sweat gland tumor, but metastatic adenocarcinoma (which can mimic sweat gland tumors) must be considered, especially if atypia is observed.
0:01:14 - Crucial Immunostain (P63/P40): P63 or P40 (an isoform of P63) is identified as the most helpful immunostain to differentiate primary cutaneous adnexal tumors (which stain strongly in the nucleus) from metastatic visceral adenocarcinomas (which are typically negative). This distinction has significant prognostic implications.
0:02:24 - Chondromyxoid Stroma and Cartilage: A key characteristic of this tumor is the presence of cartilage (evidenced by chondrocytes in lacunae) or, more commonly, chondromyxoid stroma, which is a mixoid-cartilaginous material.
0:02:57 - Myoepithelial Cells: The tumor also contains funny-looking, polygonal to epithelioid cells, described as myoepithelial cells, located within the chondromyxoid areas.
0:03:22 - Diagnosis: Mixed Tumor (Chondroid Syringoma/Pleomorphic Adenoma): The tumor is definitively identified as a mixed tumor, also known as chondroid syringoma (a term the speaker dislikes due to appearance) or pleomorphic adenoma, which is the cutaneous analog of a salivary gland pleomorphic adenoma.
0:03:48 - Myoepithelial Differentiation: The myoepithelial component of these tumors typically differentiates into soft tissue elements like bone, cartilage, and myxoid backgrounds.
0:03:57 - Malignancy Risk: The speaker warns that marked atypia should prompt suspicion for malignant myoepithelioma or myoepithelial carcinoma arising from these tumors.
0:04:07 - Myoepithelial Immunohistochemistry: Myoepithelial cells almost always express keratin and stain strongly with S100 and Sox10, an important detail for differentiating them from melanoma. Actin expression is less reliable.
0:04:44 - Genetic Considerations (Ewing's Gene): Some myoepithelial tumors, especially in soft tissue, have been reported to exhibit Ewing's (EWS) gene rearrangements, as EWS is a "promiscuous" gene that partners with various other genes.